Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Radiotherapy, Intensity-Modulated × Clear all

Phase

Phase NA 3 Phase 1 3 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 26 Squamous Cell Carcinoma of Head and Neck 6 Prostatic Neoplasms 5 Head and Neck Neoplasms 5 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Salivary Gland Neoplasms 2 Oropharyngeal Neoplasms 2 Neurotoxicity Syndromes 2 Hypopharyngeal Neoplasms 2 Glioblastoma 2 Carcinoma 2 Brain Neoplasms 2 Astrocytoma 2 Vaginal Neoplasms 1 Tongue Neoplasms 1 Thoracic Neoplasms 1 Stage II Prostate Adenocarcinoma AJCC v7 1 Sarcoma 1 Radiation Injuries 1 Precancerous Conditions 1 Papillomavirus Infections 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Adenocarcinoma 1 Ototoxicity 1 Oligodendroglioma 1 Obesity 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Capecitabine 12 Gemcitabine 11 Cyclophosphamide 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 6 Prednisone 6 Ondansetron 6 Morphine 6 Irinotecan 6 Drug Therapy 6 Doxorubicin 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5 Sodium Chloride 5 Panitumumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01403779 2022-11-07

KOSIMA

Universitätsmedizin Mannheim

Phase 3 Completed

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡